A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to Sorafenib

• Silvia Pietrobono, MD,
• Davide Melisi, MD, PhD

Affiliations

Silvia Pietrobono, MD

Digestive Molecular Clinical Oncology Research Unit, Università degli Studi di Verona, Verona, Italy

Davide Melisi, MD, PhD

Correspondence Address correspondence to: Davide Melisi, MD, PhD, Digestive Molecular Clinical Oncology Unit, Section of Medical Oncology, Department of Medicine, University of Verona, AOUI Verona–Policlinico “G.B. Rossi,” Piazzale L.A. Scuro, 10, 37134, Verona, Italy.; Digestive Molecular Clinical Oncology Research Unit, Università degli Studi di Verona, Experimental Cancer Medicine Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy